Clinical Trial Update: Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examines neoadjuvant chemotherapy for patients with moderate-risk mid-rectal cancer, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer
• Rectal Neoplasms Malignant
• Rectum Carcinoma

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Rectal Neoplasms Malignant, Rectum Carcinoma | Phase 3 | Status: UNKNOWN